Alzheimer's drug‐development pipeline: 2016

2016113 citationsJournal Articlegold Open Access

Authors

Travis Morstorf · Touro University Nevada

Abstract

Amyloid is the principal target of late-stage development programs. There are relatively few agents in clinical trials for AD suggesting a need to amplify the drug discovery ecosystem.

Topics & Keywords

Computational Drug Discovery Methods Cholinesterase and Neurodegenerative Diseases Alzheimer's disease research and treatments

Publication Details

Published in: Alzheimer s & Dementia Translational Research & Clinical Interventions

Volume 2, Issue 4, pp. 222-232

DOI: 10.1016/j.trci.2016.07.001

Field-Weighted Citation Impact: 19.51

Command Palette

Alzheimer's drug‐development pipeline: 2016

Authors

Abstract

Topics & Keywords

Publication Details